Medpace Holdings Total Assets 2014-2024 | MEDP

Medpace Holdings total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Medpace Holdings total assets for the quarter ending September 30, 2024 were $2.084B, a 40.18% increase year-over-year.
  • Medpace Holdings total assets for 2023 were $1.657B, a 22.5% increase from 2022.
  • Medpace Holdings total assets for 2022 were $1.352B, a 18.52% decline from 2021.
  • Medpace Holdings total assets for 2021 were $1.66B, a 19.36% increase from 2020.
Medpace Holdings Annual Total Assets
(Millions of US $)
2023 $1,657
2022 $1,352
2021 $1,660
2020 $1,391
2019 $1,143
2018 $968
2017 $951
2016 $979
2015 $984
2014 $1,097
2013 $0
Medpace Holdings Quarterly Total Assets
(Millions of US $)
2024-09-30 $2,084
2024-06-30 $1,920
2024-03-31 $1,796
2023-12-31 $1,657
2023-09-30 $1,487
2023-06-30 $1,407
2023-03-31 $1,396
2022-12-31 $1,352
2022-09-30 $1,328
2022-06-30 $1,315
2022-03-31 $1,344
2021-12-31 $1,660
2021-09-30 $1,577
2021-06-30 $1,470
2021-03-31 $1,451
2020-12-31 $1,391
2020-09-30 $1,296
2020-06-30 $1,222
2020-03-31 $1,138
2019-12-31 $1,143
2019-09-30 $1,072
2019-06-30 $1,017
2019-03-31 $1,007
2018-12-31 $968
2018-09-30 $950
2018-06-30 $968
2018-03-31 $973
2017-12-31 $951
2017-09-30 $949
2017-06-30 $964
2017-03-31 $966
2016-12-31 $979
2016-09-30 $976
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2014-12-31 $1,097
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $10.417B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Viatris (VTRS) United States $14.478B 4.46
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00